Memphasys Limited listed on the ASX on May 14 2007 as NuSep Holdings Limited (NSP). The Company changed its name to Memphasys in 2016 and its ordinary shares are now trading under the ASX code of 'MEM'.
Memphasys is committed to providing shareholders with complete, up-to-the-minute information about the Company. You can find contact, stock and corporate information in this section of the website and also on the Australian Securities Exchange.
(click on link above to view Prospectus)
As announced on 27 February, Memphasys is proceeding with a non-renounceable pro-rata entitlement issue on the basis of one (1) share (New Share) for every (2) shares held by elibible shareholders on the record date (7th March) at an issue price of $0.02 per New Share.
The entitlement issue, to raise up to approximately $3.64 million (before costs) (Offer) is to be fully underwriiten by Patersons Securities Limited.
The funds raised from the entitlement issue are to be used to further the development of the Felix device in preparation for commercialisation, working capital and repayment of Director loans.
New shares issued under the Offer (totaling up to 182,044,573 shares) will be listed on the ASX and will rank pari-passu with existing fully paid ordinary shares.
Commercialisation Progress and Investor Presentation
A market update on the commercialisation progress of the Felix Device was released to the ASX on January 29 2019. The announcement can be viewed by clicking this link.
An investor presentation was released to the ASX on October 30 2018. The presentation can be viewed by clicking the link.
Memphasys' Executive Chairman, Alison Coutts, presented at the Finance News Network Investor Event on September 4 2018. The presentation to investors can be viewed by clicking the above link.
Annual General Meetings
Memphasys 2018 Annual General Meeting was held on November 22 2018 at the Company's premises, 30 Richmond Road, Homebush West, NSW.
The 2017 Annual General Meeting was held on December 5 2017 at the Company's premises, 30 Richmond Road, Homebush West, NSW. For details please click on the ASX Announcements 2017 section on this page.
A General Meeting of the Company was also held on December 21 2017 at Boardroom Pty Ltd, Level 12, 225 George Street, Sydney, NSW. For details please click on the ASX Announcements 2017 section on this page.
Other Share Related Enquiries
Other share related enquires including notification of change of address should be forwarded to:
Boardroom Pty Limited
GPO Box 3993, Sydney, NSW 2001, Australia
Phone: +61 2 9290 9600
Fax: +61 2 9279 0664
The Memphasys Limited share registry is maintained by Boardroom Pty Limited. Boardroom’s website, www.boardroomlimited.com.au, offers shareholders the ability to confirm the details of their holdings and the option of receiving communications electronically. You will be required to enter your name, address and Shareholder Reference Number (SRN) to access details of your account.
Shareholders and Prospective Shareholders:
Phone: +61 2 8415 7300
Memphasys, Company Secretary, PO Box 2202, Homebush West, NSW 2140, Australia
Memphasys Limited Corporate Head Office
30 Richmond Road, Homebush West, NSW 2140, Australia
Memphasys' Investor Relations
Phone: +61 2 8415 7300